(Total Views: 286)
Posted On: 09/22/2023 6:19:53 PM
Post# of 182
NetworkNewsBreaks – SOHM Inc. (SHMN) Expands Team to Direct Global Growth Strategy
SOHM (OTC: SHMN) is a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories. “SOHM is strengthening its governing team with the addition of two experienced visionaries committed to helping the company’s growth in the pharmaceutical, nutraceutical and cosmeceutical marketplace… The new officers are expected to help direct SOHM’s global growth strategy as the company continues to develop and diversify its product offerings, which include a variety of mediums for administering antibiotics, analgesics, anti-inflammatory and anti-cold therapies, as well as vitamins,” a recent article reads. “Dr. Krishna Bhat, MD, Ph.D, FACC, an experienced bioscientist and cardiologist, will bring his leadership skills to the company’s advisory board as its new chief medical advisor, increasing his commitment beyond his involvement as a longtime shareholder… SOHM also recently announced the appointment of Dr. David Aguilar, Ph.D as chief operating officer to direct the company’s sustainability, stability, growth and new developments at its uppermost level, drawing on his 22 years of experience in the pharmaceutical industry working with clinical and regulatory needs for preclinical and IND filings of allogeneic cell-based therapies.”
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
SOHM (OTC: SHMN) is a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories. “SOHM is strengthening its governing team with the addition of two experienced visionaries committed to helping the company’s growth in the pharmaceutical, nutraceutical and cosmeceutical marketplace… The new officers are expected to help direct SOHM’s global growth strategy as the company continues to develop and diversify its product offerings, which include a variety of mediums for administering antibiotics, analgesics, anti-inflammatory and anti-cold therapies, as well as vitamins,” a recent article reads. “Dr. Krishna Bhat, MD, Ph.D, FACC, an experienced bioscientist and cardiologist, will bring his leadership skills to the company’s advisory board as its new chief medical advisor, increasing his commitment beyond his involvement as a longtime shareholder… SOHM also recently announced the appointment of Dr. David Aguilar, Ph.D as chief operating officer to direct the company’s sustainability, stability, growth and new developments at its uppermost level, drawing on his 22 years of experience in the pharmaceutical industry working with clinical and regulatory needs for preclinical and IND filings of allogeneic cell-based therapies.”
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
